期刊文献+

HPLC法测定注射用黄芩苷原料中黄芩苷及其有关物质的含量 被引量:6

Content Determination of Baicalin and Its Related Substances in Baicalin for Injection by HPLC
原文传递
导出
摘要 目的:建立测定注射用黄芩苷原料中黄芩苷及其有关物质含量的方法。方法:以高效液相色谱法测定注射用黄芩苷原料中黄芩苷及其有关物质千层纸素A-7-O葡糖醛酸苷、汉黄芩苷的含量,并以不加校正因子的主成分自身对照法计算总杂质的含量。色谱柱为Agilent ZORBAX SB-C18(150 mm×4.6 mm,5μm),流动相为甲醇-0.1%磷酸水溶液(梯度洗脱),流速为1.0 ml/min,柱温为30℃,检测波长为274 nm。结果:黄芩苷、千层纸素A-7-O葡糖醛酸苷、汉黄芩苷的质量浓度分别在50.00~300.00、0.21~6.57、0.16~0.80μg/ml范围内与各自峰面积积分值呈良好的线性关系(r分别为0.999 9、0.999 3、0.999 3);平均加样回收率分别为99.16%、100.69%、99.18%,RSD分别为1.2%、2.4%、4.6%(n均为9)。黄芩苷与有关物质分离良好,千层纸素A-7-O葡糖醛酸苷与汉黄芩苷的检出限分别为0.43、0.64 ng。结论:该方法专属性强,结果准确、可靠,可用于注射用黄芩苷原料中黄芩苷及其有关物质的含量测定。 OBJECTIVE: To establish a method for the content determination of baicalin and related substances in Baicalin for injection. METHODS: The contents of baicalin and related substance, such as oroxylin A 7-O-glucuronide, wogonoside, were de- termined by HPLC. The contents of the total impurities were computed by main constituent self-control method without calibration factor. The separation was performed on Agilent ZORBAX SB-C,8( 150 mm^4.6 ram, 5 p.m) column with mobile phase consisted of methanol-0.1%phosphoric acid solution (gradient elution) at the flow rate of 1.0 ml/min. The column temperature was 30 ~C and the detection wavelength was set at 274 nm. RESULTS: The linear ranges of baicalin, oroxylin A 7-O-glucuronide and wogonoside were 50.00-300.00 pg/ml(r=0.999 9),0.21-6.57 ~tg/ml(r----0.999 3) and 0.16-0.80 p.g/ml(r=0.999 3). Average recovery rates were 99.16% (RSD= 1.2%, n----9), 100.69% (RSD--2.4%, n----9) and 99.18% (RSD=4.6%, n-~9). Baicalin was separated from related substance well. The detection limits of oroxylin A 7-O-glucureonide and wogonside were 0.43,0.64 rig. CONCLUSIONS: The meth- od is specific, accurate and reliable, and it can be used for the content determination of baicalin and related substance in baicalin for injection.
机构地区 北京中医药大学
出处 《中国药房》 CAS CSCD 2013年第39期3694-3697,共4页 China Pharmacy
基金 国家"重大新药创制"科技重大专项课题(No.2010ZX09102)
关键词 高效液相色谱法 注射用黄芩苷原料 有关物质 含量测定 HPLC Baicalin for injection Related substance Content determination
  • 相关文献

参考文献4

二级参考文献19

  • 1薛明,冯怡,徐德生.夏枯草化学成分及药理作用的研究概况[J].江苏中医药,2005,26(5):55-57. 被引量:57
  • 2戚志华,王四旺,王剑波.高效液相色谱法测定陕西境内不同产地、不同生长期女贞子中2组分的含量[J].中国药房,2007,18(6):455-457. 被引量:13
  • 3顾晓洁,钱士辉,李友宾,李萍,段金廒.夏枯草的化学成分及药理作用研究进展[J].中国野生植物资源,2007,26(2):5-7. 被引量:52
  • 4李时珍.本草纲目[M].北京:人民卫生出版社,1985.415.
  • 5中国药典.一部[S].北京:中国医药科技出版社,2010.
  • 6苏敬.新修本草[M].安徽科学技术出版社,1981:204.
  • 7汪切庵.本草易读.卷三【M].北京:人民卫生出版社,1987:28.
  • 8蔡少青.中药质量评价和质量控制的对策[A].中国中医药研究促进会专业委员会成立大会暨"全国中药关键技术研讨会"资料汇编,2003:44.
  • 9Akao T, Kawabata K, Yanagisawa E, et al. Baicalin, the pre-dominant flavone glueuronide of Radix Seutellariae, is absorbed from the rat gastrointestinal traet as the aglycone and restored to its original form [ J]. J Pharm Pharmaeol, 2000, 52 (12) : 1563.
  • 10小祈恭一.和漢薬配糖体は天然のフ.ロドラツゲー場内細菌の役割[J].漢方研究,1995,279:74.

共引文献59

同被引文献78

  • 1任慧霞,王厚全,张建国.黄芩苷的热原反应研究[J].食品与药品,2006,8(02A):39-41. 被引量:3
  • 2万丽丽,郭澄.中药药动学研究现状和研究方向[J].中国药房,2006,17(8):627-628. 被引量:5
  • 3张先洲,祝红达,孟书舫,潘细贵.青藤碱微乳的制备及其体外经皮渗透研究[J].中国中药杂志,2007,32(19):2007-2010. 被引量:12
  • 4Wu Hao-yun, Liu Zhi-dong, Peng Jun-jie, et al. Design and evaluation of baicalin-containing in situ pH-Iriggered gelling system for sus- tained ophthalmic drug delivery [J]. International Journal of Pharma- ceutics, 2011,410(1): 31-40.
  • 5Lawrence M Jayno, Rees Gareth D. Microemulsion-based media as novel drug delivery systems [J]. Advanced Drug Delivery Reviews, 2012, (64): 175=193.
  • 6Kima BY, Doha HI, Leb TN, et al. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies [J]. Int J Pharm, 2005, 293(4): 193-202.
  • 7Pathan Ib, Setty CM. Nanoemulsion system for transdermal delivery of tamoxifen citrate: design,characterization, effect of penetration en- hane, ers and in vivo studies [J]. Digest Journal of Nanomaterials And Biostructures, 2012, 7(4): 1373-1387.
  • 8Choa CW, Shinb SC. Enhanced transdcnnal delivery of atenolol from theethylene-vinyl acetate matrix [J]. Int J Pharm, 2004, 287 (17): 67-71.
  • 9Shen, Wang Ying, Zhang Yi. Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer[J]. Int J Nanomedicine, 2011, 6:1237-1243.
  • 10Luo Mf, Shen Q, Chen Jj. Transdermal delivery ofpaconol using cu- bic gel and microemulsion gel [J]. International Journal Of Nanomedicine, 2011, 6(2): 1603-1610.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部